At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SITC SITE Centers Corp.
Closed 05-03 16:00:00 EDT
13.97
+0.11
+0.79%
盘后14.25
+0.28+2.00%
17:47 EDT
High14.17Low13.82Vol1.87M
Open14.10D1 Closing13.86Amplitude2.56%
Mkt Cap2.70BTradable Cap2.14BTotal Shares193.59M
T/O25.99MT/O Rate1.22%Tradable Shares153.12M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
SITE Centers (SITC) Receives a Buy from Stifel Nicolaus
TIPRANKS  ·  05-03 10:07
SITE Centers (SITC) Receives a Buy from Stifel Nicolaus
SITE Centers (SITC) Stock Declines Despite Q1 OFFO Beat
Zacks  ·  05-02 00:04
SITE Centers (SITC) Stock Declines Despite Q1 OFFO Beat
SITE Centers Corp. (NYSE:SITC) Q1 2024 Earnings Call Transcript
Insider Monkey  ·  05-01 22:13
SITE Centers Corp. (NYSE:SITC) Q1 2024 Earnings Call Transcript
Site Centers Corp reports results for the quarter ended in March - Earnings Summary
Reuters  ·  05-01 19:44
Site Centers Corp reports results for the quarter ended in March - Earnings Summary
SITE Centers Corp (SITC) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves and ...
GuruFocus.com  ·  05-01 15:01
SITE Centers Corp (SITC) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves and ...
SITE Centers Corp. (SITC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks  ·  04-30
SITE Centers Corp. (SITC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
SITE CENTERS CORP. (SITC) Q1 FFO and Revenues Top Estimates
Zacks  ·  04-30
SITE CENTERS CORP. (SITC) Q1 FFO and Revenues Top Estimates
SITE Centers Q1 2024 FFO $0.28 Beats $0.25 Estimate, Sales $120.621M Beat $118.013M Estimate
Benzinga  ·  04-30
SITE Centers Q1 2024 FFO $0.28 Beats $0.25 Estimate, Sales $120.621M Beat $118.013M Estimate
BRIEF-SITE Centers Q1 Net Income USD -26.3 Million Vs. IBES Estimate USD 8.5 Million
Reuters  ·  04-30
BRIEF-SITE Centers Q1 Net Income USD -26.3 Million Vs. IBES Estimate USD 8.5 Million
SITE Centers Reports First Quarter 2024 Results
Business Wire  ·  04-30
SITE Centers Reports First Quarter 2024 Results
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire  ·  04-29
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
GlobeNewswire  ·  04-29
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
Site Centers Corp expected to post earnings of 5 cents a share - Earnings Preview
Reuters  ·  04-26
Site Centers Corp expected to post earnings of 5 cents a share - Earnings Preview
Agree Realty (ADC) Q1 FFO and Revenues Surpass Estimates
Zacks  ·  04-24
Agree Realty (ADC) Q1 FFO and Revenues Surpass Estimates
Society for Immunotherapy of Cancer Publishes Recommendations on Optimal Intratumoral Immunotherapy Clinical Trial (IICT) Design
StreetInsider  ·  04-24
Society for Immunotherapy of Cancer Publishes Recommendations on Optimal Intratumoral Immunotherapy Clinical Trial (IICT) Design
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire  ·  04-22
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Press Release: SITE Centers' First Quarter 2024 Earnings Conference Call to be Held on Tuesday, April 30, 2024, at 8:00 a.m. Eastern Time
Dow Jones  ·  04-16
Press Release: SITE Centers' First Quarter 2024 Earnings Conference Call to be Held on Tuesday, April 30, 2024, at 8:00 a.m. Eastern Time
SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series
StreetInsider  ·  04-12
SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
GlobeNewswire  ·  04-09
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors

Introduction

Company Name.
SITE Centers Corp.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
SITE Centers is an owner and manager of open-air shopping centers located in suburban, high household income communities. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.
Issue price:
--